Bulls REASONS TO BUY
Bears REASONS TO SELL
December 09, 2013
(Jutia Group, 12/9/13)
[Reuters] - The U.S. Supreme Court said on Monday it would leave intact a $142 million jury verdict against Pfizer Inc over its marketing of the epilepsy drug...(read more)
(Jutia Group, 12/6/13)
[optionMONSTER] - Zoetis was spun off from Pfizer early this year, and one big investor thinks the animal spirits are ready to take over. optionMONSTER's Heat Seeker monitoring program...(read more)
(Stock Blog Hub, 9/17/13)
Pfizer Inc. (PFE) recently faced a pipeline setback with the company discontinuing a late-stage study being conducted with its oncology candidate, inotuzumab ozogamicin. The randomized,...(read more)
Pfizer (PFE) Company Overview
Pfizer Inc. (NYSE:PFE) is the largest pharmaceutical company in the world. It owns the best selling medicine in the world, cholesterol-lowering drug Lipitor and has 14 other blockbuster drugs (annual sales >$1B). In FY 2010, Pfizer generated revenues of $67.8 billion and net income of $8.26B.
As the largest player in the pharmaceutical market, Pfizer has greater power in marketing and forming alliances. The company also consistently posts the highest dividends in the industry. However, Pfizer faces challenges common to all players in the pharmaceutical industry, including issues surrounding patent expiration and FDA regulation.(Read more at Wikinvest )
What's in this PFE analysis on Wikinvest...